This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Some cookies on this site are essential, and the site won't work as expected without them. These cookies are set when you submit a form, login or interact with the site by doing something that goes beyond clicking on simple links.

We also use some non-essential cookies to anonymously track visitors or enhance your experience of the site. If you're not happy with this, we won't set these cookies but some nice features of the site may be unavailable.

Press ReleasesIn the MediaAwardsScientific PublicationsRelated LinksSubscription Press MailingMedia Contact

Press Releases

ITM’s subsidiary ITG Isotope Technologies Garching GmbH to be incorporated by name under the ITM family brand

Read more

ITM’s subsidiary ITG Isotope Technologies Garching GmbH to be incorporated by name under the ITM family brand

Read more

ITM’s subsidiary ITG Isotope Technologies Garching GmbH to be incorporated by name under the ITM family brand

Read more

Future-oriented and long-term alliance with Endocyte for the further expansion of targeted radioligand therapy with no-carrier-added Lutetium-177 for…

Read more

Funds will support ITM’s research and development strategy for cancer treatments

Financing by EU bank is provided under Investment Plan for Europe

Read more

ITM wins German Medical Award in the category “Medical Innovation Product” for outstanding patient benefit and advanced treatment approach with…

Read more

Technology license agreement for the production and distribution of ITM Germanium-68/Gallium-68 Generators and no-carrier-added (n.c.a) Lutetium-177…

Read more

Two partnership agreements signed today will lay the groundwork for a new isotope delivery system at Bruce Power that will help provide lifesaving…

Read more

ITM's subsidiary ITG and Nordic Nanovector have signed long-term global supply agreements for the medical radioisotope n.c.a. 177Lu / EndolucinBeta®

Read more

Förderung des FORActinium-Projekts durch die Bayerische Forschungsstiftung zur Entwicklung eines Herstellungsverfahrens für das in der zielgerichteten…

Read more